Krensavage Asset Management

Krensavage Asset Management as of Sept. 30, 2017

Portfolio Holdings for Krensavage Asset Management

Krensavage Asset Management holds 14 positions in its portfolio as reported in the September 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Enanta Pharmaceuticals (ENTA) 14.8 $47M 1.0M 46.80
Gilead Sciences (GILD) 13.2 $42M 521k 81.02
United Therapeutics Corporation (UTHR) 12.7 $41M 347k 117.19
Bioverativ 11.2 $36M 630k 57.07
Sucampo Pharmaceuticals 10.4 $33M 2.8M 11.80
Merck & Co (MRK) 7.7 $25M 384k 64.03
Orthofix International Nv Com Stk 7.2 $23M 487k 47.25
Halyard Health 6.7 $22M 479k 45.03
RTI Biologics 6.3 $20M 4.4M 4.55
Invacare Corporation 5.5 $18M 1.1M 15.75
CONMED Corporation (CNMD) 3.1 $10M 192k 52.47
Aviragen Therapeutics 0.6 $2.0M 2.8M 0.69
Digirad Corporation 0.4 $1.2M 334k 3.45
Juniper Pharmaceuticals Incorporated 0.3 $1.1M 243k 4.55